Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study
M Drysdale, ER Galimov… - BMJ Open …, 2024 - bmjopenrespres.bmj.com
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study
M Drysdale, ER Galimov… - BMJ open …, 2024 - pubmed.ncbi.nlm.nih.gov
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
[PDF][PDF] Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study
M Drysdale, ER Galimov, MJ Yarwood, V Patel… - Respir …, 2024 - scienceopen.com
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
[HTML][HTML] Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort …
M Drysdale, ER Galimov, MJ Yarwood… - BMJ Open …, 2024 - ncbi.nlm.nih.gov
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
[PDF][PDF] Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study
M Drysdale, ER Galimov, MJ Yarwood… - Respir …, 2024 - pdfs.semanticscholar.org
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study.
M Drysdale, ER Galimov, MJ Yarwood… - BMJ Open …, 2024 - europepmc.org
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study.
M Drysdale, ER Galimov, MJ Yarwood… - BMJ Open …, 2024 - europepmc.org
Background We assessed the effectiveness of sotrovimab vs no early COVID-19 treatment in
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …
highest-risk COVID-19 patients during Omicron predominance. Methods Retrospective …